BG Medicine, Inc. announced that its Board of Directors has appointed Stephen P. Hall, as the company's Executive Vice President, Chief Financial Officer. Mr. Hall most recently held the position of Vice President Finance, Treasurer, Principal Financial and Chief Accounting Officer at Stemline Therapeutics, a publicly traded clinical stage biopharmaceutical company, where he helped execute financings in excess of $100 million. Prior to joining Stemline Therapeutics, Mr. Hall served as Chief Financial Officer at both life science and medical device companies, including Orthocon, Inc., Helicos BioSciences Corporation, TriPath Imaging, Inc., and Colorado MEDtech.

Mr. Hall will replace Charles Abdalian, who has served as BG Medicine's CFO since October 2012.